N.H. Choi-Miura
Department of Physiological Chemistry
School of Pharmaceutical Sciences
Showa University
Shinagawa
Japan
Name/email consistency: high
- Novel human plasma proteins, IHRP (acute phase protein) and PHBP (serine protease), which bind to glycosaminoglycans. Choi-Miura, N.H. Curr. Med. Chem. Cardiovasc. Hematol. Agents (2004)
- SP-40,40 is a component of plasminogen activator inhibitor-1-binding protein and stabilizes plasminogen activator inhibitor-1 activity. Choi-Miura, N. Biol. Pharm. Bull. (2001)
- Identification of the substrates for plasma hyaluronan binding protein. Choi-Miura, N.H., Yoda, M., Saito, K., Takahashi, K., Tomita, M. Biol. Pharm. Bull. (2001)
- Quantitative measurement of the novel human plasma protein, IHRP, by sandwich ELISA. Choi-Miura, N.H. Biol. Pharm. Bull. (2001)
- Regulation mechanism of the serine protease activity of plasma hyaluronan binding protein. Choi-Miura, N.H., Saito, K., Takahashi, K., Yoda, M., Tomita, M. Biol. Pharm. Bull. (2001)
- Proteolytic activation and inactivation of the serine protease activity of plasma hyaluronan binding protein. Choi-Miura, N.H., Takahashi, K., Yoda, M., Saito, K., Mazda, T., Tomita, M. Biol. Pharm. Bull. (2001)
- Hepatic injury-specific conversion of mouse plasma hyaluronan binding protein to the active hetero-dimer form. Choi-Miura, N.H., Otsuyama, K., Sano, Y., Saito, K., Takahashi, K., Tomita, M. Biol. Pharm. Bull. (2001)
- The novel acute phase protein, IHRP, inhibits actin polymerization and phagocytosis of polymorphonuclear cells. Choi-Miura, N.H., Takahashi, K., Yoda, M., Saito, K., Hori, M., Ozaki, H., Mazda, T., Tomita, M. Inflamm. Res. (2000)